Anti-TUG antibody [EPR8616] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal TUG antibody. Carrier free. Suitable for WB and reacts with Mouse, Human samples.
View Alternative Names
ASPL, RCC17, TUG, UBXD9, UBXN9, ASPSCR1, Tether containing UBX domain for GLUT4, Alveolar soft part sarcoma chromosomal region candidate gene 1 protein, Alveolar soft part sarcoma locus, Renal papillary cell carcinoma protein 17, UBX domain-containing protein 9
- WB
Unknown
Western blot - Anti-TUG antibody [EPR8616] - BSA and Azide free (AB248377)
This data was developed using ab131217, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-TUG antibody [EPR8616] - BSA and Azide free (ab248377) at 1/10000 dilution
Lane 1:
K562 cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
SW480 cell lysate at 10 µg
Predicted band size: 60 kDa
false
- WB
Lab
Western blot - Anti-TUG antibody [EPR8616] - BSA and Azide free (AB248377)
This data was developed using ab131217, the same antibody clone in a different buffer formulation.
Lane 1 Wild-type HAP1 cell lysate (20 μg)
Lane 2 TUG knockout HAP1 cell lysate (20 μg)
Lane 3 NIH/3T3 cell lysate (20 μg)
Lane 4 HEK293 cell lysate (20 μg)
Lanes 1 - 4 Merged signal (red and green). Green - ab131217 observed at 70 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab131217 was shown to specifically react with TUG when TUG knockout samples were used. Wild-type and TUG knockout samples were subjected to SDS-PAGE. ab131217 and ab8245 (loading control to GAPDH) were both diluted 1/10000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TUG antibody [EPR8616] (<a href='/en-us/products/primary-antibodies/tug-antibody-epr8616-ab131217'>ab131217</a>)
Predicted band size: 60 kDa
false
Related conjugates and formulations (1)
-
Anti-TUG antibody [EPR8616]
Reactivity data
Product details
ab248377 is the carrier-free version of ab131217.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TUG regulates glucose homeostasis and energy balance. It forms a complex with GLUT4-containing vesicles controlling their movement to the plasma membrane in response to insulin stimulation. When insulin is present TUG undergoes proteolytic cleavage releasing GLUT4 so that it can facilitate glucose uptake into cells. This regulation of glucose transport is essential in maintaining normal blood glucose levels.
Pathways
TUG operates within the insulin signaling pathway and glucose transport pathway. By interacting with GLUT4 TUG controls its translocation important for insulin-mediated glucose uptake. Another significant pathway involving TUG is the trafficking of proteins through the Golgi apparatus where TUG might interact with other UBX domain-containing proteins to manage vesicular traffic.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com